enGene Therapeutics Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 7.
AI score 7 (80% interval 5–8) · evidence grade D · US · Pharma / Chemicals
Stated reason: On June 15, 2026, the Company announced the implementation of a plan to reduce its workforce by approximately 50% to streamline operations and preserve cash. The Company’s board of directors (the “Board”) approved this strategic restructuring, effective June 14, 2026, in order to preserve shareholder capital as the Company awaits additional durability data and meetings with the Food and Drug Administration (“FDA”) in…
Why 7: Cost-cutting / efficiency · Drivers: industry AI exposure +0.5, role AI exposure +0.2
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.811, industry exposure 0.712, AI investment 0.0, contrary 0.0 · named roles: Bookkeeping, Accounting, and Auditing Clerks, Computer and Information Systems Managers, General and Operations Managers, Loan Interviewers and Clerks, Office C
Headcount basis: not disclosed
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
